止血剤・組織密閉剤の世界市場:製品別(局所止血剤、接着剤・組織シーラント)、地域別、セグメント予測

◆英語タイトル:Hemostasis And Tissue Sealing Agents Market Size, Share & Trends Analysis Report By Product (Topical Hemostat, Adhesives & Tissue Sealant), By Region, And Segment Forecasts, 2019 - 2026
◆商品コード:GVW903091
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2019年2月28日
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Multi UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD7,950 ⇒換算¥826,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、止血剤・組織密閉剤の世界市場について調査・分析し、止血剤・組織密閉剤の世界市場動向、止血剤・組織密閉剤の世界市場規模、市場予測、セグメント別止血剤・組織密閉剤市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global hemostasis and tissue sealing agents market size is expected to reach USD 10.34 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 8.7% during the forecast period. The agents have gained popularity over time due to their ability to prevent blood loss. Rapid growth of minimal invasive technology and demand for faster recovery by patients is expected to promote market growth over the forecast period.
According to the Centers for Disease Control and Prevention (CDC), approximately 150 million of American population is currently suffering from at least one chronic condition, which leads to surgeries and even mortality at times. An estimate over the rising incidence was made by the CDC, which concluded that over 48% of the entire American population is expected to suffer by chronic condition.

The hemostasis and tissue sealing agents market is expected to witness lucrative growth over the next seven years owing to, an increase in demand supported by rising surgery volumes. Growth in geriatric population and prevalence of chronic conditions are the impact rendering drivers for this industry.

Further key findings from the report suggest:

• The hemostats market is expected to expand at a CAGR of over 8.7% over the forecast period owing to the rise in global volume of surgeries and applicability of the product across a variety of surgeries to avoid occurrence of hypovolemic shock, thrombocytopenia, blood transfusions, and post-operative complications

• Flowable hemostats are a combination of active and mechanical agents. They function by blocking blood flow and also converting fibrinogen into fibrin for coagulation. This segment is expected to witness a lucrative CAGR of over 10.0% from 2018 to 2026

• Some key players operating in the hemostasis and tissue sealing agents market include Johnson & Johnson; CryoLife Inc.; Pfizer; C R Bard; B Braun; Covidien; and Smith & Nephew. Market participants are involved in technological advancements to ensure sustainability and regional presence

• For instance, in March 2015, Ethicon announced higher efficiency of EVARREST fibrin sealant patch as compared to its substitute, TachoSil patch (Baxter). Further study would be conducted at the St. Vincent Heart Centre of Indiana to understand added advantages that the product can offer.

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Hemostasis and Tissue Sealing Agents Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis
3.4. User perspective analysis
3.4.1. Consumer Behavior Analysis
3.4.2. Market Influencer Analysis
3.5. List of Key End-users
3.6. Regulatory Framework
3.6.1. Reimbursement framework
3.6.2. Standards & Compliances
3.7. Market Dynamics
3.7.1. Market Driver Analysis
3.7.1.1. Increasing incidence rate of chronic conditions
3.7.1.2. Applicability of products across multiple conditions
3.7.1.3. Growing geriatric population
3.7.2. Market Restraint Analysis
3.7.2.1. Stringent regulations and approvals
3.7.3. Industry Challenges
3.7.3.1. Associated complications
3.8. Hemostasis and Tissue Sealing Agents: Market Analysis Tools
3.8.1. Industry Analysis – Porter’s
3.8.1.1. Supplier Power: (High)
3.8.1.2. Buyer Power: (Moderate)
3.8.1.3. Substitution Threat: (Moderate)
3.8.1.4. Threat from new entrant: (High)
3.8.1.5. Competitive rivalry: (High)
3.8.2. PESTEL Analysis
3.8.2.1. Political Landscape
3.8.2.2. Environmental Landscape
3.8.2.3. Social Landscape
3.8.2.4. Technology Landscape
3.8.2.5. Legal Landscape
3.8.3. Major Deals & Strategic Alliances Analysis
3.8.3.1. Joint Ventures
3.8.3.2. Mergers & Acquisitions
3.8.3.3. Licensing & Partnership
3.8.3.4. Technology Collaborations
3.8.3.5. Strategic Divestments
3.8.4. Market Entry Strategies
3.8.5. Case Studies
Chapter 4. Hemostasis and Tissue Sealing Agents Market: Segment Analysis, By Product, 2015 – 2026 (USD Million)
4.1. Definitions & Scope
4.2. Component market share analysis, 2018 & 2026
4.3. Segment Dashboard
4.4. Global Hemostasis and Tissue Sealing Agents Market, By Product, 2015 to 2026
4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
4.5.1. Topical hemostats
4.5.1.1. Active
4.5.1.2. Mechanical
4.5.1.3. Flowable
4.5.2. Adhesive & tissue sealant
4.5.2.1. Synthetic
4.5.2.2. Natural
4.5.2.3. Adhesion barrier
Chapter 5. Hemostasis and Tissue Sealing Agents Market: Regional Market Analysis, By Region, 2015 – 2026 (USD Million)
5.1. Definitions & Scope
5.2. Regional market share analysis, 2018 & 2026
5.3. Regional Market Dashboard
5.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
5.5. Regional Market Share and Leading Players, 2018
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
5.6. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
5.6.1. North America
5.6.2. Europe
5.6.3. Asia Pacific
5.6.4. Latin America
5.6.5. Middle East & Africa
5.7. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2026:
5.8. North America
5.8.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
5.8.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.8.3. U.S.
5.8.3.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.8.4. Canada
5.8.4.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9. Europe
5.9.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
5.9.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9.3. Germany
5.9.3.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9.4. U.K.
5.9.4.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9.5. France
5.9.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9.6. Italy
5.9.6.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9.7. Spain
5.9.7.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10. Asia Pacific
5.10.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
5.10.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10.3. China
5.10.3.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10.4. Japan
5.10.4.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10.5. India
5.10.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10.6. Thailand
5.10.6.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10.7. South Korea
5.10.7.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.11. Latin America
5.11.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
5.11.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.11.3. Brazil
5.11.3.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.11.4. Mexico
5.11.4.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.11.5. Argentina
5.11.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.11.6. Colombia
5.11.6.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.12. Middle East and Africa
5.12.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
5.12.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.12.3. South Africa
5.12.3.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.12.4. Saudi Arabia
5.12.4.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.12.5. UAE
5.12.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
Chapter 6. Hemostasis and Tissue Sealing Agents Market – Competitive Analysis
6.1. Recent developments & impact analysis, by key market participants
6.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2018
6.4. Public Companies
6.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
6.4.2. Company Market Share/Ranking, by region
6.4.3. Competitive Dashboard Analysis
6.4.3.1. Market Differentiators
6.4.3.2. Synergy Analysis: Major Deals & Strategic Alliances
6.5. Private Companies
6.5.1. List of key emerging companies’ /technology disruptors/innovators
6.5.2. Funding Outlook (Optional)
6.5.3. Regional network map
6.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
6.6. Supplier Ranking
6.7. Key companies profiled
6.7.1. Johnson & Johnson
6.7.1.1. Company Overview
6.7.1.2. Financial Performance
6.7.1.3. Product Benchmarking
6.7.1.4. Strategic Initiatives
6.7.2. CryoLife Inc.
6.7.2.1. Company Overview
6.7.2.2. Financial Performance
6.7.2.3. Product Benchmarking
6.7.2.4. Strategic Initiatives
6.7.3. Advance Medical Solution (AMS) Group Plc.
6.7.3.1. Company Overview
6.7.3.2. Financial Performance
6.7.3.3. Product Benchmarking
6.7.3.4. Strategic Initiatives
6.7.4. Cohera Medical Inc.
6.7.4.1. Company Overview
6.7.4.2. Financial Performance
6.7.4.3. Product Benchmarking
6.7.4.4. Strategic Initiatives
6.7.5. Integra Life Sciences Corporation
6.7.5.1. Company Overview
6.7.5.2. Financial Performance
6.7.5.3. Product Benchmarking
6.7.5.4. Strategic Initiatives
6.7.6. Pfizer Inc.
6.7.6.1. Company Overview
6.7.6.2. Financial Performance
6.7.6.3. Product Benchmarking
6.7.6.4. Strategic Initiatives
6.7.7. C R Bard Inc.
6.7.7.1. Company Overview
6.7.7.2. Financial Performance
6.7.7.3. Product Benchmarking
6.7.7.4. Strategic Initiatives
6.7.8. Cohesion Technologies Inc.
6.7.8.1. Company Overview
6.7.8.2. Financial Performance
6.7.8.3. Product Benchmarking
6.7.8.4. Strategic Initiatives
6.7.9. HyperBranch Medical Technology.
6.7.9.1. Company Overview
6.7.9.2. Financial Performance
6.7.9.3. Product Benchmarking
6.7.9.4. Strategic Initiatives
6.7.10. Biomet Inc.
6.7.10.1. Company Overview
6.7.10.2. Financial Performance
6.7.10.3. Product Benchmarking
6.7.10.4. Strategic Initiatives
6.7.11. Covidien Plc.
6.7.11.1. Company Overview
6.7.11.2. Financial Performance
6.7.11.3. Product Benchmarking
6.7.11.4. Strategic Initiatives
6.7.12. B Braun Medical Inc.
6.7.12.1. Company Overview
6.7.12.2. Financial Performance
6.7.12.3. Product Benchmarking
6.7.12.4. Strategic Initiatives
6.7.13. Smith & Nephew.
6.7.13.1. Company Overview
6.7.13.2. Financial Performance
6.7.13.3. Product Benchmarking
6.7.13.4. Strategic Initiatives
Chapter 7. KOL Commentary
Chapter 8. Recommendation

List of Tables

Table 1 North America Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 2 U.S. Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 3 Canada Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 4 Europe Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 5 U.K. Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 6 Germany Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 7 France Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 8 Italy Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 9 Spain Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 10 Asia Pacific Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 11 Japan Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 12 China Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 13 India Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 14 Thailand Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 15 South Korea Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 16 Latin America Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 17 Brazil Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 18 Mexico Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 19 Argentina Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 20 Colombia Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 21 MEA Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 22 South Africa Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 23 Saudi Arabia Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)
Table 24 UAE Hemostasis and Tissue Sealing Agents Market, by Product, 2015 - 2026 (USD Million)

List of Figures

Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain based sizing & forecasting
Figure 6 QFD modelling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Global hemostasis and tissue sealing agents market segmentation
Figure 9 Global hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 10 Hemostasis and tissue sealing agents market dynamics
Figure 11 Number of individual in the U.S. with chronic condition (Estimates in Millions)
Figure 12 Rising geriatric population, by geography, (% increase)
Figure 13 Key opportunities prioritized
Figure 14 Hemostasis and tissue sealing agents market Porter’s analysis
Figure 15 Hemostasis and tissue sealing agents company market share, 201
Figure 16 Hemostasis and tissue sealing agents market PESTEL analysis
Figure 17 Hemostasis and tissue sealing agents market share, by product, 2018 & 2026
Figure 18 Topical hemostats market, 2015 - 2026 (USD Million)
Figure 19 Active hemostats market, 2015 - 2026 (USD Million)
Figure 20 Mechanical hemostats market, 2015 - 2026 (USD Million)
Figure 21 Flowable hemostats market, 2015 - 2026 (USD Million)
Figure 22 Adhesives and tissue sealants market, 2015 - 2026 (USD Million)
Figure 23 Synthetic tissue sealants market, 2015 - 2026 (USD Million)
Figure 24 Natural tissue sealants market, 2015 - 2026 (USD Million)
Figure 25 Adhesion barrier products market, 2015 - 2026 (USD Million)
Figure 26 Hemostasis and tissue sealing agents market share, by region, 2018 & 2026
Figure 27 North America hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 28 U.S. hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 29 Canada hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 30 Europe hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 31 U.K. hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 32 Germany hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 33 France hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 34 Italy hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 35 Spain hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 36 Asia Pacific hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 37 Japan hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 38 China hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 39 Thailand hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 40 South korea hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 41 India hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 42 Latin America hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 43 Brazil hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 44 Mexico hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 45 Argentina hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 46 Colombia hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 47 MEA hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 48 South Africa hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 49 Saudi arabia hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)
Figure 50 UAE hemostasis and tissue sealing agents market, 2015 - 2026 (USD Million)

【掲載企業】

Johnson & Johnson、CryoLife Inc.、Advance Medical Solution (AMS) Group Plc.、Cohera Medical Inc.、Integra Life Sciences Corporation、Pfizer Inc.、C R Bard Inc.、Cohesion Technologies Inc.、HyperBranch Medical Technology.、Biomet Inc.、Covidien Plc.、B Braun Medical Inc.、Smith & Nephew.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[止血剤・組織密閉剤の世界市場:製品別(局所止血剤、接着剤・組織シーラント)、地域別、セグメント予測]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆